ITGA2 and nasopharyngeal carcinoma: Since only 3% of NPC patients carry this high risk haplotype block CGC the application of hOGG1 Ser326Cys, ITGA2 C807T and XPD Lys751Gln as a diagnostic marker in a mass preventive screening program appears to be unfeasible.